PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, School of Medical Sciences, University of Campinas, 13083-887 Campinas, São Paulo, Brazil.\', \'Obesity and Comorbidities Research Center, University of Campinas, 13083-864 Campinas, São Paulo, Brazil.\', \'School of Nursing, University of Campinas, 13083-887 Campinas, São Paulo, Brazil.\', \'Autoimmune Research Lab, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, 13083-862 Campinas, São Paulo, Brazil.\', \'Department of Surgery, School of Medical Sciences, University of Campinas, 13083-887 Campinas, São Paulo, Brazil.\', \'Department of Radiology, School of Medical Sciences, University of Campinas, 13083-887 Campinas, São Paulo, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 30910.3390/v13020309
?:hasPublicationType
?:journal
  • Viruses
is ?:pmid of
?:pmid
?:pmid
  • 33669276
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.805
?:rankingScore_hIndex
  • 52
is ?:relation_isRelatedTo_publication of
?:title
  • Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin-Kallikrein System in Severe COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all